Electrophysiological Analysis of human Pluripotent Stem Cell-derived Cardiomyocytes (hPSC-CMs) Using Multi-electrode Arrays (MEAs).

作者: Luca Sala , Dorien Ward-van Oostwaard , Leon G. J. Tertoolen , Christine L Mummery , Milena Bellin

DOI: 10.3791/55587

关键词: Induced pluripotent stem cellPharmacologyEmbryonic stem cellElectrophysiologySafety pharmacologyNeuroscienceCardiac arrhythmiaStem cellLong QT syndromeMyocyteMedicine

摘要: Cardiomyocytes can now be derived with high efficiency from both human embryonic and induced-Pluripotent Stem Cells (hPSC). hPSC-derived cardiomyocytes (hPSC-CMs) are increasingly recognized as having great value for modeling cardiovascular diseases in humans, especially arrhythmia syndromes. They have also demonstrated relevance vitro systems predicting drug responses, which makes them potentially useful drug-screening discovery, safety pharmacology perhaps eventually personalized medicine. This would facilitated by deriving hPSC-CMs patients or susceptible individuals hiPSCs. For all applications, however, precise measurement analysis of hPSC-CM electrical properties essential identifying changes due to cardiac ion channel mutations and/or drugs that target channels cause sudden death. Compared manual patch-clamp, multi-electrode array (MEA) devices offer the advantage allowing medium- high-throughput recordings. protocol describes how dissociate 2D cell cultures small aggregates single cells plate on MEAs record their spontaneous activity field potential. Methods analyzing recorded data extract specific parameters, such QT RR intervals, described here. Changes these parameters expected carrying responsible arrhythmias following addition drugs, detection those carry a cardiotoxic risk.

参考文章(60)
Maya Fuerstenau-Sharp, Martina E. Zimmermann, Klaus Stark, Nico Jentsch, Melanie Klingenstein, Marzena Drzymalski, Stefan Wagner, Lars S. Maier, Ute Hehr, Andrea Baessler, Marcus Fischer, Christian Hengstenberg, Generation of Highly Purified Human Cardiomyocytes from Peripheral Blood Mononuclear Cell-Derived Induced Pluripotent Stem Cells PLOS ONE. ,vol. 10, pp. e0126596- ,(2015) , 10.1371/JOURNAL.PONE.0126596
Christiaan C. Veerman, Georgios Kosmidis, Christine L. Mummery, Simona Casini, Arie O. Verkerk, Milena Bellin, Immaturity of Human Stem-Cell-Derived Cardiomyocytes in Culture: Fatal Flaw or Soluble Problem? Stem Cells and Development. ,vol. 24, pp. 1035- 1052 ,(2015) , 10.1089/SCD.2014.0533
I. Karakikes, M. Ameen, V. Termglinchan, J. C. Wu, Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Insights into Molecular, Cellular, and Functional Phenotypes Circulation Research. ,vol. 117, pp. 80- 88 ,(2015) , 10.1161/CIRCRESAHA.117.305365
Karim Sallam, Yingxin Li, Philip T. Sager, Steven R. Houser, Joseph C. Wu, Finding the Rhythm of Sudden Cardiac Death: New Opportunities Using Induced Pluripotent Stem Cell–Derived Cardiomyocytes Circulation Research. ,vol. 116, pp. 1989- 2004 ,(2015) , 10.1161/CIRCRESAHA.116.304494
Shugo Tohyama, Fumiyuki Hattori, Motoaki Sano, Takako Hishiki, Yoshiko Nagahata, Tomomi Matsuura, Hisayuki Hashimoto, Tomoyuki Suzuki, Hiromi Yamashita, Yusuke Satoh, Toru Egashira, Tomohisa Seki, Naoto Muraoka, Hiroyuki Yamakawa, Yasuyuki Ohgino, Tomofumi Tanaka, Masatoshi Yoichi, Shinsuke Yuasa, Mitsushige Murata, Makoto Suematsu, Keiichi Fukuda, Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. Cell Stem Cell. ,vol. 12, pp. 127- 137 ,(2013) , 10.1016/J.STEM.2012.09.013
Steven J. Kattman, Alec D. Witty, Mark Gagliardi, Nicole C. Dubois, Maryam Niapour, Akitsu Hotta, James Ellis, Gordon Keller, Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell. ,vol. 8, pp. 228- 240 ,(2011) , 10.1016/J.STEM.2010.12.008
Dongrui Ma, Heming Wei, Yongxing Zhao, Jun Lu, Guang Li, Norliza Binte Esmail Sahib, Teng Hong Tan, Keng Yean Wong, Winston Shim, Philip Wong, Stuart A. Cook, Reginald Liew, Modeling type 3 long QT syndrome with cardiomyocytes derived from patient-specific induced pluripotent stem cells. International Journal of Cardiology. ,vol. 168, pp. 5277- 5286 ,(2013) , 10.1016/J.IJCARD.2013.08.015
Ioannis Karakikes, Grant D. Senyei, Jens Hansen, Chi-Wing Kong, Evren U. Azeloglu, Francesca Stillitano, Deborah K. Lieu, Jiaxian Wang, Lihuan Ren, Jean-Sebastien Hulot, Ravi Iyengar, Ronald A. Li, Roger J. Hajjar, Small Molecule-Mediated Directed Differentiation of Human Embryonic Stem Cells Toward Ventricular Cardiomyocytes Stem Cells Translational Medicine. ,vol. 3, pp. 18- 31 ,(2014) , 10.5966/SCTM.2013-0110
Lior Gepstein, Amira Gepstein, Joseph Itskovitz-Eldor, Dorit Kenyagin-Karsenti, Ofer Binah, Hana Segev, Izhak Kehat, Michal Amit, Erella Livne, Mirit Snir, Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. Journal of Clinical Investigation. ,vol. 108, pp. 407- 414 ,(2001) , 10.1172/JCI12131